2 weeks Ago By Defense World Staff
Evolent Health, Inc. ( NYSE:EVH – Get Free Report ) shares hit a new 52-week low during mid-day trading on Thursday after Citigroup lowered their price target on the stock from $33.00 to $21.
00. Citigroup currently has a buy rating on the stock. Evolent Health traded as low as $12.
33 and last traded at $12.44, with a volume of 1120664 shares. The stock had previously closed at $12.
75. A number of other brokerages also recently issued reports on EVH. Stephens downgraded Evolent Health from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $38.
00 to $16.00 in a research note on Friday, November 8th. JPMorgan Chase & Co.
raised their price objective on Evolent Health from $36.00 to $45.00 and gave the stock an “overweight” rating in a research report on Monday, August 19th.
Truist Financial reissued a “buy” rating and set a $33.00 price objective on shares of Evolent Health in a research report on Tuesday, August 27th. JMP Securities cut their price objective on Evolent Health from $34.
00 to $31.00 and set a “market outperform” rating for the company in a research report on Friday, August 9th. Finally, Barclays cut their price objective on Evolent Health from $39.
00 to $19.00 and set an “overweight” rating for the company in a research report on Monday. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock.
Based on data from MarketBeat.com, Evolent Health currently has a consensus rating of “Buy” and an average price target of $29.50.
Check Out Our Latest Research Report on Evolent Health Insider Activity at Evolent Health Institutional Investors Weigh In On Evolent Health Institutional investors have recently added to or reduced their stakes in the business. Headlands Technologies LLC purchased a new stake in Evolent Health during the first quarter worth approximately $46,000. Covestor Ltd increased its position in Evolent Health by 138.
1% during the third quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock worth $40,000 after buying an additional 826 shares during the period. GAMMA Investing LLC increased its position in Evolent Health by 5,365.
5% during the third quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock worth $45,000 after buying an additional 1,556 shares during the period. Quarry LP acquired a new position in Evolent Health during the second quarter worth approximately $32,000.
Finally, Canada Pension Plan Investment Board acquired a new position in Evolent Health during the second quarter worth approximately $61,000. Evolent Health Stock Performance The company has a market cap of $1.47 billion, a price-to-earnings ratio of -13.
92 and a beta of 1.58. The firm has a 50-day simple moving average of $25.
47 and a 200 day simple moving average of $24.45. The company has a quick ratio of 1.
08, a current ratio of 1.04 and a debt-to-equity ratio of 0.58.
Evolent Health Company Profile ( Get Free Report ) Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Read More Five stocks we like better than Evolent Health What is a Death Cross in Stocks? 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick What Are Growth Stocks and Investing in Them Mouse Rising: The Iger Investment Pays Off for Disney Investors Why Are Stock Sectors Important to Successful Investing? Can CAVA Stock Be the Next Chipotle? Earnings Can Help Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter ..
